121 related articles for article (PubMed ID: 10817560)
1. Detection of cellular microchimerism of male or female origin in systemic sclerosis patients by polymerase chain reaction analysis of HLA-Cw antigens.
Artlett CM; Cox LA; Jimenez SA
Arthritis Rheum; 2000 May; 43(5):1062-7. PubMed ID: 10817560
[TBL] [Abstract][Full Text] [Related]
2. HLA-DQA1 is not an apparent risk factor for microchimerism in patients with various autoimmune diseases and in healthy individuals.
Artlett CM; O'Hanlon TP; Lopez AM; Song YW; Miller FW; Rider LG
Arthritis Rheum; 2003 Sep; 48(9):2567-72. PubMed ID: 13130476
[TBL] [Abstract][Full Text] [Related]
3. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis.
Artlett CM; Smith JB; Jimenez SA
N Engl J Med; 1998 Apr; 338(17):1186-91. PubMed ID: 9554859
[TBL] [Abstract][Full Text] [Related]
4. Quantification of fetal microchimeric cells in clinically affected and unaffected skin of patients with systemic sclerosis.
Sawaya HH; Jimenez SA; Artlett CM
Rheumatology (Oxford); 2004 Aug; 43(8):965-8. PubMed ID: 15199216
[TBL] [Abstract][Full Text] [Related]
5. Quantification of maternal microchimerism by HLA-specific real-time polymerase chain reaction: studies of healthy women and women with scleroderma.
Lambert NC; Erickson TD; Yan Z; Pang JM; Guthrie KA; Furst DE; Nelson JL
Arthritis Rheum; 2004 Mar; 50(3):906-14. PubMed ID: 15022334
[TBL] [Abstract][Full Text] [Related]
6. Systemic sclerosis-rheumatoid arthritis overlap syndrome: a unique combination of features suggests a distinct genetic, serological and clinical entity.
Szücs G; Szekanecz Z; Zilahi E; Kapitány A; Baráth S; Szamosi S; Végvári A; Szabó Z; Szántó S; Czirják L; György Kiss C
Rheumatology (Oxford); 2007 Jun; 46(6):989-93. PubMed ID: 17384178
[TBL] [Abstract][Full Text] [Related]
7. [Microchimerisme in systemic sclerosis].
Aractingi S; Regnier S
Ann Med Interne (Paris); 2002 May; 153(3):189-91. PubMed ID: 12218902
[TBL] [Abstract][Full Text] [Related]
8. Fetal cell microchimerism in tissue from multiple sites in women with systemic sclerosis.
Johnson KL; Nelson JL; Furst DE; McSweeney PA; Roberts DJ; Zhen DK; Bianchi DW
Arthritis Rheum; 2001 Aug; 44(8):1848-54. PubMed ID: 11508438
[TBL] [Abstract][Full Text] [Related]
9. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma.
Nelson JL; Furst DE; Maloney S; Gooley T; Evans PC; Smith A; Bean MA; Ober C; Bianchi DW
Lancet; 1998 Feb; 351(9102):559-62. PubMed ID: 9492775
[TBL] [Abstract][Full Text] [Related]
10. Skewed X chromosome inactivation in blood cells of women with scleroderma.
Ozbalkan Z; Bagişlar S; Kiraz S; Akyerli CB; Ozer HT; Yavuz S; Birlik AM; Calgüneri M; Ozçelik T
Arthritis Rheum; 2005 May; 52(5):1564-70. PubMed ID: 15880831
[TBL] [Abstract][Full Text] [Related]
11. Clonal T-cell populations are frequent in the skin and blood of patients with systemic sclerosis.
Kreuter A; Höxtermann S; Tigges C; Hahn SA; Altmeyer P; Gambichler T
Br J Dermatol; 2009 Oct; 161(4):785-90. PubMed ID: 19523172
[TBL] [Abstract][Full Text] [Related]
12. Male microchimerism and HLA compatibility in French women with sclerodema: a different profile in limited and diffuse subset.
Rak JM; Pagni PP; Tiev K; Allanore Y; Farge D; Harlé JR; Launay D; Hachulla E; Didelot R; Cabane J; Kahan A; Martin M; Granel B; Roudier J; Lambert NC
Rheumatology (Oxford); 2009 Apr; 48(4):363-6. PubMed ID: 19208687
[TBL] [Abstract][Full Text] [Related]
13. Increased numbers of microchimeric cells of fetal origin are associated with dermal fibrosis in mice following injection of vinyl chloride.
Christner PJ; Artlett CM; Conway RF; Jiménez SA
Arthritis Rheum; 2000 Nov; 43(11):2598-605. PubMed ID: 11083286
[TBL] [Abstract][Full Text] [Related]
14. Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin.
Ohtsuka T; Yamazaki S
Br J Dermatol; 2004 Jun; 150(6):1091-5. PubMed ID: 15214893
[TBL] [Abstract][Full Text] [Related]
15. Association between the HLA-DRB1 gene and clinical features of systemic sclerosis in Korea.
Joung CI; Jun JB; Chung WT; Song GG; Choe JY; Chang HK; Yoo DH
Scand J Rheumatol; 2006; 35(1):39-43. PubMed ID: 16467040
[TBL] [Abstract][Full Text] [Related]
16. Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis.
Manetti M; Liakouli V; Fatini C; Cipriani P; Bonino C; Vettori S; Guiducci S; Montecucco C; Abbate R; Valentini G; Matucci-Cerinic M; Giacomelli R; Ibba-Manneschi L
Ann Rheum Dis; 2009 Mar; 68(3):408-11. PubMed ID: 18930992
[TBL] [Abstract][Full Text] [Related]
17. Association of a functional CD19 polymorphism with susceptibility to systemic sclerosis.
Tsuchiya N; Kuroki K; Fujimoto M; Murakami Y; Tedder TF; Tokunaga K; Takehara K; Sato S
Arthritis Rheum; 2004 Dec; 50(12):4002-7. PubMed ID: 15593213
[TBL] [Abstract][Full Text] [Related]
18. Feto-maternal microchimerism in connective tissue diseases.
Gannagé M; Amoura Z; Lantz O; Piette JC; Caillat-Zucman S
Eur J Immunol; 2002 Dec; 32(12):3405-13. PubMed ID: 12432571
[TBL] [Abstract][Full Text] [Related]
19. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
[TBL] [Abstract][Full Text] [Related]
20. Male microchimerism in healthy women and women with scleroderma: cells or circulating DNA? A quantitative answer.
Lambert NC; Lo YM; Erickson TD; Tylee TS; Guthrie KA; Furst DE; Nelson JL
Blood; 2002 Oct; 100(8):2845-51. PubMed ID: 12351394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
